fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Getting ahead of neuropathic pain

Written by | 13 Dec 2012

by Bruce Sylvester – Researchers at Boston Children’s Hospital and the Massachusetts Institute of Technology report the discovery a potential method to delay the onset of neuropathic pain.

Getting ahead of neuropathic pain

Written by | 21 Nov 2012

by Bruce Sylvester – Researchers at Boston Children’s Hospital and the Massachusetts Institute of Technology report the discovery a potential method to delay the onset of neuropathic pain.

ASCO 2012 Report – Bendamustine with Rituximab: More than doubles PFS in certain lymphoma patients

Written by | 20 Nov 2012

by Marybeth Burke – Initial combination chemotherapy with bendamustine and rituximab more than doubled progression-free survival to nearly 6 years compared with standard R-CHOP therapy among patients with… read more.

ASCO 2012 Report – Trametinib delays tumour growth and extends survival in certain melanoma patients

Written by | 20 Nov 2012

by Marybeth Burke – Median progression-free survival (PFS) was significantly greater in the trametinib group, 4.8 months, vs the chemotherapy group, 1.4 months, according to a study presented

ASCO 2012 Report – U.S. Cancer drug shortages plague treatment in certain areas

Written by | 20 Nov 2012

by Marybeth Burke – Some of the most essential mainstays in cancer treatment drugs for adults and children are in short supply, Michael Link, M.D., president of the… read more.

ICS 2012 Report – Potentially inappropriate medicines in heart failure

Written by | 31 Oct 2012

by Edel O’Connell – Report on poster presented at the ICS Annual Meeting

ICS 2012 Report – The world’s first fully implantable artificial heart has been designed three decades after the world’s first human heart transplant

Written by | 31 Oct 2012

by Edel O’Connell reporting on the presentation by Professor Alain Carpentier.

Incentives for smaller medicines makers

Written by | 26 Oct 2012

by Gary Finnegan – Emerging uses of EMA Approved Drugs – Over 1,000 small and medium enterprises (SMEs) have now registered with European Medicines Agency SME office. The… read more.

‘Pineapple’ treatment for burn wounds

Written by | 26 Oct 2012

by Gary Finnegan – Emerging uses of EMA Approved Drugs – The CHMP has recommended the first medical treatment for the removal of eschar from severe burn wounds.

First new drug for IBS

Written by | 26 Oct 2012

by Gary Finnegan – Emerging uses of EMA Approved Drugs – The EMA has given the green light for the first medicine specifically for irritable bowel syndrome (IBS)… read more.

New leader for key medicines panel

Written by | 26 Oct 2012

by Gary Finnegan – Emerging uses of EMA Approved Drugs – There’s a new man at the helm of the European Medicine Agency’s most influential committee: Dr Tomas… read more.

Adalimumab appears promising in pediatric crohn’s disease

Written by | 26 Oct 2012

by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Adalimumab appears to be effective in maintaining remission among some pediatric patients with Crohn’s disease.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.